nafronyl and Hyperhomocysteinemia

nafronyl has been researched along with Hyperhomocysteinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Landi, A	1

Reviews

1 review(s) available for nafronyl and Hyperhomocysteinemia

Article	Year
[Secondary prevention and conservative therapy of obliterative arteriosclerosis]. Orvosi hetilap, 2004, May-16, Volume: 145, Issue:20 Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematologic Agents; Hemodilution; Hemorheology; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrrolidines; Risk Factors; Smoking; Tetrazoles; Vasodilator Agents; Walking	2004

Article

Year

[Secondary prevention and conservative therapy of obliterative arteriosclerosis].

Orvosi hetilap, 2004, May-16, Volume: 145, Issue:20

Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematologic Agents; Hemodilution; Hemorheology; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrrolidines; Risk Factors; Smoking; Tetrazoles; Vasodilator Agents; Walking

2004